Dataset Information

Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in heart.

ABSTRACT: Kinase/phosphatase balance governs cardiac excitability in health and disease. Although detailed mechanisms for cardiac kinase regulation are established, far less is known regarding cardiac protein phosphatase 2A (PP2A) regulation. This is largely due to the complexity of the PP2A holoenzyme structure (combinatorial assembly of three subunit enzyme from >17 subunit genes) and the inability to segregate "global" PP2A function from the activities of multiple "local" holoenzyme populations. Here we report that PP2A catalytic, regulatory, and scaffolding subunits are tightly regulated at transcriptional, translational, and post-translational levels to tune myocyte function at base line and in disease. We show that past global read-outs of cellular PP2A activity more appropriately represent the collective activity of numerous individual PP2A holoenzymes, each displaying a specific subcellular localization (dictated by select PP2A regulatory subunits) as well as local specific post-translational catalytic subunit methylation and phosphorylation events that regulate local and rapid holoenzyme assembly/disassembly (via leucine carboxymethyltransferase 1/phosphatase methylesterase 1 (LCMT-1/PME-1). We report that PP2A subunits are selectively regulated between human and animal models, across cardiac chambers, and even within specific cardiac cell types. Moreover, this regulation can be rapidly tuned in response to cellular activation. Finally, we report that global PP2A is altered in human and experimental models of heart disease, yet each pathology displays its own distinct molecular signature though specific PP2A subunit modulatory events. These new data provide an initial view into the signaling pathways that govern PP2A function in heart but also establish the first step in defining specific PP2A regulatory targets in health and disease.

SUBMITTER: DeGrande ST

PROVIDER: S-EPMC3542989 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in heart.

DeGrande Sean T ST Little Sean C SC Nixon Derek J DJ Wright Patrick P Snyder Jedidiah J Dun Wen W Murphy Nathaniel N Kilic Ahmet A Higgins Robert R Binkley Philip F PF Boyden Penelope A PA Carnes Cynthia A CA Anderson Mark E ME Hund Thomas J TJ Mohler Peter J PJ

The Journal of biological chemistry 20121130 2

Kinase/phosphatase balance governs cardiac excitability in health and disease. Although detailed mechanisms for cardiac kinase regulation are established, far less is known regarding cardiac protein phosphatase 2A (PP2A) regulation. This is largely due to the complexity of the PP2A holoenzyme structure (combinatorial assembly of three subunit enzyme from >17 subunit genes) and the inability to segregate "global" PP2A function from the activities of multiple "local" holoenzyme populations. Here w ...[more]

PMID: 23204520

Similar Datasets

Project description:BACKGROUND:Type 2A protein phosphatase (PP2A) enzymes are serine/threonine phosphatases which comprise a scaffold A subunit, a regulatory B subunit and a catalytic C subunit, and have been implicated in the dephosphorylation of multiple cardiac phosphoproteins. B subunits determine subcellular targeting, substrate specificity and catalytic activity, and can themselves be regulated by post-translational modifications. We explored potential ?-adrenergic regulation of PP2A in cardiomyocytes through phosphorylation of the regulatory B subunit isoform B56?. METHODS AND RESULTS:Phosphate affinity SDS-PAGE and immunoblot analysis revealed increased phosphorylation of B56? in adult rat ventricular myocytes (ARVM) exposed to the ?-adrenergic receptor (?AR) agonist isoprenaline (ISO). Phosphorylation of B56? occurred at S573, primarily through stimulation of the ?1AR subtype, and was dependent on PKA activity. The functional role of the phosphorylation was explored in ARVM transduced with adenoviruses expressing wild type (WT) or non-phosphorylatable (S573A) B56?, fused to GFP at the N-terminus. C subunit expression was increased in ARVM expressing GFP-B56?-WT or GFP-B56?-S573A, both of which co-immunoprecipitated with endogenous C and A subunits. PP2A activity in cell lysates was increased in response to ISO in ARVM expressing GFP-B56?-WT but not GFP-B56?-S573A. Immunoblot analysis of the phosphoproteome in ARVM expressing GFP-B56?-WT or GFP-B56?-S573A with antibodies detecting (i) phospho-serine/threonine residues in distinct kinase substrate motifs or (ii) specific phosphorylated residues of functional importance in selected proteins revealed a comparable phosphorylation profile in the absence or presence of ISO stimulation. CONCLUSIONS:In cardiomyocytes, ?AR stimulation induces PKA-mediated phosphorylation of the PP2A regulatory subunit isoform B56? at S573, which increases associated PP2A catalytic activity. This is likely to regulate the phosphorylation status of specific B56?-PP2A substrates, which remain to be identified.

Dataset Information

Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in heart.

Publications

Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in heart.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets